Search results for "Kinetic"

showing 10 items of 3064 documents

Determination of the technetium-99m mercaptoacetyltriglycine plasma clearance in children by means of a single blood sample: a multicentre study

1993

A multicentre European study was undertaken in order to determine a reasonable algorithm allowing the determination of overall technetium-99m mercaptoacetyltriglycine clearance using a single blood sample. Employing multiple blood sample clearance as a reference method, it was shown that an acceptable estimation of the MAG3 renal clearance could be obtained using a blood sample taken at any time between 30 and 40 min after tracer injection. After correction for body surface area, comparison of clearance determined using (a) the single blood sample and (b) the multiple blood samples provided a coefficient of correlation of 0.949 and an SEE of 27 ml/min. This algorithm is valid for clearance …

Body surface areaTechnetium-99m-MercaptoacetyltriglycinePlasma clearancebusiness.industrySample (material)Renal functionGeneral MedicinePharmacokineticsBlood plasmaMedicineRadiology Nuclear Medicine and imagingbusinessNuclear medicineClearanceEuropean Journal of Nuclear Medicine
researchProduct

Anthropometric measurements of the body composition of cancer patients determine the precise role of the body surface area and the calculation of the…

2012

The calculation of an accurate dose of chemotherapy for oncological patients reduces the possible medication errors and the toxicity of the body and so it improves the outcome of the treatment (survival). In oncological practice for the calculation of the dose of chemotherapy the human body surface area (BSA) is used. The human body surface area is determined by derived formulas, but it is not directly linked to the pharmacokinetics of the drugs. Pharmacokinetic studies have demonstrated that for the calculation of the chemotherapy dose the actual body weight should be taken into account rather than the ideal one. In the therapeutic dose determination the body fat mass has essential signifi…

Body surface areamedicine.medical_specialtyChemotherapyBody volume indexChemistrymedicine.medical_treatmentUrologyBody adiposity indexAnthropometryEndocrinologyPharmacokineticsClassification of obesityInternal medicinemedicineBody mass indexPapers on Anthropology
researchProduct

Many-body Green's function theory of electrons and nuclei beyond the Born-Oppenheimer approximation

2020

The method of many-body Green's functions is developed for arbitrary systems of electrons and nuclei starting from the full (beyond Born-Oppenheimer) Hamiltonian of Coulomb interactions and kinetic energies. The theory presented here resolves the problems arising from the translational and rotational invariance of this Hamiltonian that afflict the existing many-body Green's function theories. We derive a coupled set of exact equations for the electronic and nuclear Green's functions and provide a systematic way to approximately compute the properties of arbitrary many-body systems of electrons and nuclei beyond the Born-Oppenheimer approximation. The case of crystalline solids is discussed …

Born–Oppenheimer approximationFOS: Physical sciences02 engineering and technologyElectronKinetic energy01 natural sciencesMany bodytiiviin aineen fysiikkaGreen's function methodssymbols.namesake0103 physical sciencesCoulombkvanttifysiikka010306 general physicsPhysicsQuantum PhysicsExact differential equation021001 nanoscience & nanotechnologyMany-body techniquesCondensed Matter - Other Condensed MatterClassical mechanicssymbolsRotational invarianceCrystalline systemsapproksimointiQuantum Physics (quant-ph)0210 nano-technologyHamiltonian (quantum mechanics)Other Condensed Matter (cond-mat.other)
researchProduct

Resolving Binding Events on the Multifunctional Human Serum Albumin

2020

Abstract Physiological processes rely on initial recognition events between cellular components and other molecules or modalities. Biomolecules can have multiple sites or mode of interaction with other molecular entities, so that a resolution of the individual binding events in terms of spatial localization as well as association and dissociation kinetics is required for a meaningful description. Here we describe a trichromatic fluorescent binding‐ and displacement assay for simultaneous monitoring of three individual binding sites in the important transporter and binding protein human serum albumin. Independent investigations of binding events by X‐ray crystallography and time‐resolved dyn…

Boron Compounds540 Chemistry and allied sciencesalbumin bindingIbuprofenSerum Albumin HumanMolecular Dynamics SimulationCrystallography X-Ray01 natural sciencesBiochemistryFluorescenceDrug DiscoverymedicineHumansSpatial localizationmulticolor assayskinetics investigationsGeneral Pharmacology Toxicology and PharmaceuticsBinding sitePharmacologychemistry.chemical_classificationBinding SitesMolecular Structure010405 organic chemistryBinding proteinBiomoleculeCommunicationOrganic ChemistryLauric AcidsTransporterdrug interactionsHuman serum albuminFluorescenceCommunications0104 chemical sciences010404 medicinal & biomolecular chemistry4-Chloro-7-nitrobenzofurazanchemistry540 ChemieBiophysicsMolecular MedicineDissociation kineticsswitchSENSE technologyWarfarinmedicine.drugChemmedchem
researchProduct

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin Hydrochloride.

2020

Abstract In this monograph, literature data is reviewed to evaluate the feasibility of waiving in vivo bioequivalence testing and instead applying the Biopharmaceutics Classification System (BCS) based methods to the approval of immediate-release solid oral dosage forms containing moxifloxacin hydrochloride as the sole active pharmaceutical ingredient. To facilitate the feasibility decision, solubility and permeability and dissolution characteristics in the context of the BCS, therapeutic index, therapeutic use, pharmacokinetic parameters, bioequivalence/bioavailability issues, drug-excipient interactions and other relevant data were taken into consideration. Moxifloxacin is a BCS class I d…

Break pointBiowaiverMoxifloxacinPharmaceutical ScienceAdministration OralBiological AvailabilityContext (language use)02 engineering and technologyPharmacologyBioequivalenceMoxifloxacin hydrochloride030226 pharmacology & pharmacyDosage formMoxifloxacin hydrochloridePermeabilityBiopharmaceutics03 medical and health sciences0302 clinical medicineMoxifloxacinMedicinePharmacokineticsTherapeutic indexActive ingredientDosage Formsbusiness.industryBiopharmaceutics Classification System021001 nanoscience & nanotechnologyBiopharmaceutics Classification SystemBioavailabilityPharmacodynamicsSolubilityTherapeutic Equivalency0210 nano-technologybusinessmedicine.drugJournal of pharmaceutical sciences
researchProduct

Combination of ozonation and photocatalysis for purification of aqueous effluents containing formic acid as probe pollutant and bromide ion

2014

The treatment by advanced oxidation processes (AOPs) of waters contaminated by organic pollutants and containing also innocuous bromide ions may generate bromate ions as a co-product. In the present work heterogeneous photocatalysis and ozonation have individually been applied and in combination (integrated process) to degrade the organic compounds in water containing also bromide anions. The results show that: i) the sole photocatalysis does not produce bromate ions and in the case of its presence, it is able to reduce bromate to innocuous bromide ions; ii) the integration of photocatalysis and ozonation synergistically enhances the oxidation capabilities; and iii) in the integrated proces…

BromidesTime FactorsEnvironmental EngineeringFormatesTime FactorAdvanced oxidation processes; Bromate; Ozonation; Photocatalysis; Photocatalytic ozonation; Water purification; Bromates; Bromides; Catalysis; Formates; Ions; Kinetics; Oxidation-Reduction; Ozone; Time Factors; Water Pollutants Chemical; Ultraviolet Rays; Waste Disposal Fluid; Water Purification; Water Science and Technology; Waste Management and Disposal; Pollution; Ecological ModelingUltraviolet RaysFormic acidInorganic chemistryPortable water purificationWaste Disposal FluidCatalysisCatalysiCatalysischemistry.chemical_compoundOzonePhotocatalysiBromideOzonationIonWaste Management and DisposalBromateWater Science and TechnologyCivil and Structural EngineeringIonsKineticPhotocatalytic ozonationSettore ING-IND/24 - Principi Di Ingegneria ChimicaAqueous solutionWater purificationBromatesEcological ModelingFormateBromatePollutionKineticschemistryUltraviolet RayBromidePhotocatalysisOxidation-ReductionWater Pollutants ChemicalAdvanced oxidation processeWaste disposalWater Research
researchProduct

Binding of Bacillus thuringiensis toxins in resistant and susceptible strains of pink bollworm (Pectinophora gossypiella)

2003

Abstract Evolution of resistance by pests could cut short the success of transgenic plants producing toxins from Bacillus thuringiensis, such as Bt cotton. The most common mechanism of insect resistance to B. thuringiensis is reduced binding of toxins to target sites in the brush border membrane of the larval midgut. We compared toxin binding in resistant and susceptible strains of Pectinophora gossypiella, a major pest of cotton worldwide. Using Cry1Ab and Cry1Ac labeled with 125I and brush border membrane vesicles (BBMV), competition experiments were performed with unlabeled Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca, Cry1Ja, Cry2Aa, and Cry9Ca. In the susceptible strain, Cry1Aa, Cry1Ab, Cry1…

Brush borderBacterial ToxinsBacillus thuringiensisGenetically modified cropsBinding CompetitiveBiochemistryMicrobiologyIodine RadioisotopesRadioligand AssayBacillus thuringiensisBotanyAnimalsPest Control BiologicalMolecular BiologyBinding SitesMicrovillibiologyHeliothis virescensCytoplasmic Vesiclesfungifood and beveragesPlutellabiology.organism_classificationRecombinant ProteinsLepidopteraKineticsBt cottonCry1AcLarvaInsect ScienceProtein BindingPink bollwormInsect Biochemistry and Molecular Biology
researchProduct

Biotransformation in vitro of the 22R and 22S epimers of budesonide by human liver, bronchus, colonic mucosa and skin.

2001

The pharmacological effects of glucocorticoids are greatly influenced by their pharmacokinetic properties. In the present report, the in vitro biotransformation of the 22R and 22S epimers of the topical steroid budesonide was studied in the S-9 fraction of human liver, bronchus, skin and colonic mucosa. The disappearance of unchanged epimers of budesonide was measured during 90 min of incubation by high performance liquid chromatography. The rate of disappearance was high in human liver while little biotransformation occurred in bronchial tissue and colonic mucosa, and none was detected in the skin. A marked decay of the initial concentration of unchanged budesonide epimers was noticed afte…

Budesonidemedicine.medical_specialtyColonAdministration TopicalAnti-Inflammatory AgentsBronchiCell LineTherapeutic indexPharmacokineticsBiotransformationInternal medicineCulture TechniquesmedicineHumansPharmacology (medical)Intestinal MucosaBudesonideIncubationGlucocorticoidsBiotransformationCells CulturedSkinPharmacologyBronchusChemistryStereoisomerismIn vitroEndocrinologymedicine.anatomical_structureLiverHepatocytesEpimermedicine.drugFundamentalclinical pharmacology
researchProduct

24-h efficacy and pharmacokinetics of tiotropium Respimat® 5 μg in patients with asthma

2015

Background: Once-daily tiotropium Respimat® (tioR) add-on therapy has demonstrated efficacy in patients with moderate symptomatic asthma. Aim and Objectives: To investigate whether dosing regimen (QD vs BID) affected 24-h bronchodilator efficacy and exposure of tioR. Methods: 2 randomised, double-blind, crossover trials (trial 1, NCT01152450 [placebo-controlled]; trial 2, NCT01696071); 4-week treatments of tioR 5 µg QD, 2.5 µg BID and placebo Respimat® (pboR) added to medium-dose ICS (400-800 µg budesonide or equivalent). Primary end point (Week 4): area under the curve response for FEV1 (FEV1 AUC(0-24h)) (trial 1, tioR vs pboR; trial 2, QD vs BID). Pharmacokinetic end points (steady state)…

Budesonidemedicine.medical_specialtyRespimatmedicine.drug_classbusiness.industryArea under the curvePlaceboGastroenterologyPharmacokineticsInternal medicineBronchodilatormedicineClinical endpointDosingbusinessmedicine.drug5.3 Allergy and Immunology
researchProduct

1023 – Therapeutic drug-monitoring of bupropion for depression

2013

Introduction Therapeutic Drug-Monitoring (TDM) for bupropion is limited by bupropion's instability at room temperature and by the absence of a well-defined therapeutic reference range. Further it is unclear to what extent bupropion and its metabolites contribute to therapeutic effects, though hydroxybupropion seems to account for the major antidepressant effects. Aim The aim of this examination was to check if measurement of only hydroxybupropion is useful to guide the antidepressant therapy with bupropion. Methods Hydroxybupropion plasma levels were measured by high performance liquid chromatography with ultra violet detection and related to therapeutic effects measured by the Clinical Glo…

Bupropionmedicine.diagnostic_testbusiness.industryTherapeutic effectReference rangeHydroxybupropionPharmacologyPsychiatry and Mental healthPharmacokineticsTherapeutic drug monitoringAnesthesiamedicineClinical Global ImpressionAntidepressantbusinessmedicine.drugEuropean Psychiatry
researchProduct